Trends in the market for drug delivery devices categorized as combination drugs and medical devices and regulatory challenges for autoinjectors in Japan [PDF]
Frontiers in Medical TechnologyBackgroundAlthough a variety of drug delivery devices have been launched in recent years, few studies have comprehensively investigated the market trends of combination drugs and medical devices approved or certified in Japan and the regulatory ...
Makiko Mochizuki, Hideki Maeda
doaj +4 more sources
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery [PDF]
Frontiers in Pharmacology, 2022 New hypoglycemic drugs, including glucagon-like peptide 1 receptor agonists (GLP-1RA), dipeptidyl peptidase-4 inhibitors (DPP-4i) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i), which brings more options for the treatment of type 2 diabetes ...
Xiayun Ni +3 more
doaj +2 more sources
Study of possibility physical interactions antimalarial combination drugs [PDF]
Infectious Disease Reports, 2020 Identification of solid state to investigate the possibility of physical interaction between Antimalarial Artemisinin Combination Treatment base Artesunate (AS) and Amodiaquine (AQ) by hot contact method Kofler, cold contact method (crystallization ...
Timbul Partogi H. Simorangkir
doaj +2 more sources
Persistence and treatment patterns of fixed combination drugs for glaucoma: a retrospective claims database study in Japan [PDF]
BMC Ophthalmology, 2020 Background Poor persistence with glaucoma therapy can lead to disease progression and subsequent blindness. Persistence with second-line glaucoma combination treatment in a Japanese real-world setting and whether it differed from fixed and unfixed ...
Kenji Kashiwagi +3 more
doaj +2 more sources
Platinum-based drugs and hydrogel: a promising anti-tumor combination
Drug Delivery, 2023 Platinum-based drugs are widely used as first-line anti-tumor chemotherapy agents. However, they also have nonnegligible side effects due to the free drugs in circulation.
Jiamin Yao +3 more
doaj +3 more sources
Biomolecules, 2022 Drug combination and drug repurposing are two strategies that allow to find novel oncological therapies, in a faster and more economical process. In our previous studies, we developed a novel model of drug combination using antineoplastic and different ...
Diana Duarte +3 more
doaj +3 more sources
Current Issues in Molecular Biology, 2022 Our group developed a new model of drug combination consisting of the use of antineoplastic drugs and different repurposed drugs, having demonstrated that antimalarial and central nervous system (CNS) drugs have a promising anticancer profile as ...
Diana Duarte, Inês Guerreiro, Nuno Vale
doaj +3 more sources
Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis [PDF]
, 2020 Aim: A study was conducted to evaluate the ameliorative potential of homeopathic drugs in combination (Sulfur 30C, Thuja 30C, Graphites 30C, and Psorinum 30C) in 16 dogs affected with oral papillomatosis which was not undergone any previous treatment ...
Kumar, M. Asok +5 more
core +2 more sources
Acute respiratory viral infections: possibilities of symptomatic therapy of patients
Медицинский совет, 2021 Acute respiratory viral infections are widespread in the human population. High contagiosity, a wide variety of pathogens, the possibility of rapid changes in the genotype of the virus and, accordingly,cause the development of drug resistance, make it ...
G. N. Nikiforova +3 more
doaj +1 more source
Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds. [PDF]
, 2020 Hundreds of trials are being conducted to evaluate combination of newer targeted drugs as well as immunotherapy. Our aim was to compare efficacy and safety of combination versus single non-cytotoxic anticancer agents. We searched PubMed (01/01/2001 to 03/
Barkauskas, Donald A +4 more
core +1 more source